ZNF404 include a range of compounds that influence various signaling pathways leading to the functional activation of the protein. Forskolin, a known activator of adenylyl cyclase, increases intracellular cAMP levels, which in turn can enhance ZNF404 activity via PKA-dependent phosphorylation. Similarly, Dibutyryl-cAMP, a cAMP analog, directly activates PKA, creating a conducive environment for the phosphorylation and consequent activation of ZNF404. Activation can also be achieved through the modulation of intracellular calcium levels, as seen with Ionomycin, which increases calcium concentration and activates calmodulin-dependent pathways, leading to the activation of ZNF404 through calcium-sensitive signaling processes. Thapsigargin, by inhibiting SERCA, also elevates cytoplasmic calcium levels, which can lead to the activation of calcium-dependent kinases that target ZNF404.
Several growth factors and hormones directly activate pathways that can lead to the activation of ZNF404. Insulin, through its activation of the PI3K/AKT pathway, and Epidermal Growth Factor (EGF), through its effect on the EGFR pathway, initiate cascades that can lead to the activation of ZNF404 by kinases such as AKT. Phorbol 12-myristate 13-acetate (PMA) activates PKC, which is another kinase capable of phosphorylating and activating ZNF404. Anisomycin, by activating the JNK/SAPK pathway, can also lead to the activation of transcription factors that may target ZNF404. Isoproterenol activates beta-adrenergic receptors, resulting in increased cAMP and subsequent PKA activation, which can phosphorylate and activate ZNF404. Vascular Endothelial Growth Factor (VEGF) activates its receptor pathway, leading to a cascade that can culminate in the activation of ZNF404 through kinase-mediated phosphorylation. These diverse compounds, by targeting different signaling molecules and pathways, can all contribute to the activation of ZNF404, illustrating the complex network of cellular processes that converge on the regulation of this protein.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which could lead to the phosphorylation and activation of ZNF404 as part of downstream signaling. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium concentration, which can activate calmodulin-dependent pathways potentially leading to the functional activation of ZNF404 through calcium-sensitive signaling processes. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates the PI3K/AKT signaling pathway, which may lead to the activation of ZNF404 through phosphorylation by AKT or other downstream kinases. | ||||||
Bradykinin | 58-82-2 | sc-507311 | 5 mg | $110.00 | ||
Bradykinin activates the PLC pathway, leading to PKC activation, which might then activate ZNF404 as part of its downstream effects. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a potent activator of the JNK/SAPK signaling pathway, which can lead to the activation of transcription factors and potentially ZNF404 as a downstream target. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cell-permeable cAMP analog that activates PKA and could lead to the activation of ZNF404 by phosphorylation through cAMP-dependent pathways. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol activates beta-adrenergic receptors, leading to increased cAMP and activation of PKA, which might then activate ZNF404 through phosphorylation. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to increased cytosolic calcium levels, which can activate ZNF404 through calcium-mediated signaling pathways. | ||||||